PERSPECTIVE OF INNOVATION DRUG FORMULATION WITH DARUNAVIR ETHANOLAT
Article shows the results of development and technological issues of darunavir ethanolate in capsule form. Soluplus was used to increase the biopharmaceutical characteristics of current drug formulation. Results of dissolution profile studies shows that intensity and release rate of API from the cap...
Saved in:
| Main Authors: | S. A. Zolotov, N. B. Diomina, G. F. Vasilenko, M. S. Demin |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
LLC Center of Pharmaceutical Analytics (LLC «CPHA»)
2019-01-01
|
| Series: | Разработка и регистрация лекарственных средств |
| Subjects: | |
| Online Access: | https://www.pharmjournal.ru/jour/article/view/155 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Formulation and release testing of mecobalamin in gelatin capsule derived from striped Snakehead (Channa striata)
by: Mayang Sari, et al.
Published: (2025-07-01) -
Sustained-Release Solid Dispersions of Fenofibrate for Simultaneous Enhancement of the Extent and Duration of Drug Exposure
by: Seong-Jin Park, et al.
Published: (2024-12-01) -
<i>In-vitro</i> dissolution profiles comparison for various drugs with active ingredient Febuxostat commercially available on the Russian market
by: S. V. Denkina, et al.
Published: (2024-01-01) -
The Effect of Solvents and Drying Temperature on the Physicochemical Properties of Darunavir and Darunavir Ethanolate Substances
by: S. A. Zolotov, et al.
Published: (2021-02-01) -
Laser Microinterferometry for API Solubility and Phase Equilibria: Darunavir as a Case Example
by: Veronika Makarova, et al.
Published: (2025-07-01)